Sustainability
As a pharmaceutical and healthcare company, STADA is responsible for ensuring the group-wide safety of its products and thus also the safety of patients. That’s what SDG 17 is all about.
Select your country
Websites worldwide
Select a country to go to the website of the respective STADA sales company.
Australia (1)
Austria (1)
Belarus (1)
Belgium (1)
Bosnia-Herzegovina (1)
Bulgaria (1)
China (1)
Croatia (1)
Czech Republic (2)
Denmark (1)
France (1)
Hungary (1)
Ireland (1)
Italy (1)
Montenegro (1)
Netherlands (2)
Poland (1)
Portugal (1)
Romania (1)
Saudi Arabia (1)
Serbia (1)
Slovakia (1)
Slovenia (1)
Spain (1)
Switzerland (1)
The Phillippines (1)
United Arab Emirates (1)
United Kingdom (3)
Vietnam (2)
Explore STADA
Your opportunity for success with STADA
We are looking for qualified employees who drive our company forward with their specialist knowledge and commitment. We offer appealing conditions with diverse and exciting tasks as well as good career prospects and a motivating working environment.
With Clonmel Healthcare, STADA Group is Ireland’s leading supplier of prescription and consumer healthcare medicines.
Peter Goldschmidt, CEO, STADA
🏆 Congratulations to CTRL+ALT+DEFEAT - E-Learning Hackathon Champions!
By Tara Rodic,
💥 STADA EXPO 2024 Walmark was a blast!
By ,
The celebration of the 35th anniversary of STADA Pymepharco in Vietnam was, for me, an opportunity to meet and exchange ...
By Stéphane Jacqmin, EVP Emerging Markets at STADA Group
STADA supplies medicines to patients in Ukraine in various ways.
By ,
It was a pleasure to return to Frankfurt School of Finance & Management last week and ...
By , Director ESO Specialties/Biologics at STADA Group
STADA Voices
Latest news
26/07/2024
European Commission approval to expand label & patient group for IgA Nephropathy orphan medicine
24/06/2024
STADA Health Report 2024: Satisfaction with healthcare systems continues to decline
28/05/2024
Bio-Thera and STADA Reach Exclusive Agreement for BAT2506, a Proposed Golimumab Biosimilar, EU and UK
21/05/2024
STADA reduces carbon emissions and increases its renewable energy supply on sustainability journey
10/05/2024
Xbrane, STADA partner with Valorum Biologics to commercialize ranibizumab biosimilar candidate in the US
10/01/2024
STADA and Alvotech secure approval for Uzpruvo, Europe’s first ustekinumab biosimilar to Stelara
Over 2,000 visitors including families, schools, community as well as key stakeholders and business partners enjoyed this unique experience.
The STADA Walmark Team extends heartfelt thanks to everyone who joined us and for the wonderful feedback received. Your participation made the event truly special 🙏
👇 Here’s a snapshot from the incredible five days in Trinec.
#STADA #STADAEXPO #EXPOWalmark2024